Efficacy and safety of pemafibrate (K-877), a selective peroxisome proliferator-activated receptor α modulator,in patients with dyslipidemia: Results from a 24-week,randomized, double blind,active-controlled,phase 3 trial 期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

Efficacy and safety of pemafibrate (K-877), a selective peroxisome proliferator-activated receptor α modulator,in patients with dyslipidemia: Results from a 24-week,randomized, double blind,active-controlled,phase 3 trial

摘要：
收稿时间：	2017-06-16
本文献已被 ScienceDirect 等数据库收录！